{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T09:05:43Z","timestamp":1683104743563},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.nucmedbio.2003.12.007","type":"journal-article","created":{"date-parts":[[2004,4,19]],"date-time":"2004-04-19T07:26:56Z","timestamp":1082359616000},"page":"511-522","source":"Crossref","is-referenced-by-count":7,"title":["Technetium-99m labeled 1-(4-fluorobenzyl)-4-(2-mercapto-2-methyl-4-azapentyl)-4-(2-mercapto-2-methylpropylamino)-piperidine and iodine-123 metaiodobenzylguanidine for studying cardiac adrenergic function: a comparison of the uptake characteristics in vascular smooth muscle cells and neonatal cardiac myocytes, and an investigation in rats"],"prefix":"10.1016","volume":"31","author":[{"given":"Samuel","family":"Samnick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Scheuer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"M\u00fcnks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amr M.","family":"El-Gibaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Menger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl-Martin","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB1","doi-asserted-by":"crossref","unstructured":"Manger WM. Adrenergic involvement in cardiac pathophysiology. In: Manger WM, editor. Catecholamines in normal and abnormal cardiac function. New York: Karger; 1982","DOI":"10.1159\/000406934"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s00259-001-0694-0","article-title":"Alterations of the sympathetic nervous system and metabolic performance of the cardiomyopathic heart","volume":"29","author":"Bengel","year":"2000","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB3","first-page":"203","article-title":"\u03b21- and \u03b22-adrenoceptors in the human heart","volume":"43","author":"Brodde","year":"1991","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/01.RES.82.1.57","article-title":"Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy","volume":"82","author":"Schafers","year":"1998","journal-title":"Circ Res"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB5","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/BF00401768","article-title":"Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy","volume":"38","author":"Schnell","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB6","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJM199108293250905","article-title":"Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias","volume":"325","author":"Meredith","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB7","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJM199108293250911","article-title":"Sympathetic stimulation and arrhythmias","volume":"325","author":"Zipes","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB8","doi-asserted-by":"crossref","first-page":"3B","DOI":"10.1016\/0002-9149(86)90991-4","article-title":"Development of arrhythmias in the patient with congestive heart failure","volume":"57","author":"Francis","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB9","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/0735-1097(93)90541-8","article-title":"Regional cardiac sympathetic denervation in patients with ventricular tachycardia in the absence of coronary artery disease","volume":"22","author":"Mitrani","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB10","first-page":"202","article-title":"Sudden cardiac death. Neural-cardiac interactions","volume":"76","author":"Zipes","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB11","first-page":"1062","article-title":"Cardiac neurotransmission imaging","volume":"42","author":"Carrio","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB12","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/01.CIR.79.3.634","article-title":"Scintigraphic assessment of regional cardiac adrenergic innervation","volume":"79","author":"Dae","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s002590050243","article-title":"Cardiac sympathetic neurotransmission scintigraphy","volume":"25","author":"Schafers","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/01.CIR.82.2.457","article-title":"Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography","volume":"82","author":"Schwaiger","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0969-8051(01)00210-4","article-title":"Assessment of cardiac sympathetic nerve integrity with positron emission tomography","volume":"28","author":"Raffel","year":"2001","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB16","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1007\/BF02940065","article-title":"Imaging of myocardial sympathetic innervation with metaiodobenzylguanidine","volume":"1","author":"Dae","year":"1994","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB17","first-page":"1620","article-title":"Meta-iodobenzylguanindine as an index of the adrenergic nervous system integrity and function","volume":"28","author":"Sisson","year":"1987","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB18","first-page":"292","article-title":"A simple and rapid routine preparation of no-carrier added meta-I-123- and I-131-iodobenzylguanidine (I-123-MIBG and I-131-MIBG) for clinical nuclear medicine applications","volume":"38","author":"Samnick","year":"1999","journal-title":"Nucl Med"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB19","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/00006231-199906000-00008","article-title":"Improved labeling of no-carrier-added meta-[123I]iodobenzylguanidine and preliminary clinical evaluation in patients with ventricular arrhythmias","volume":"20","author":"Samnick","year":"1999","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB20","first-page":"52","article-title":"Technetium-99m labeled 4-fluorobenzylpiperidine and iodine-123 metaiodobenzylguanidine for studying myocardial adrenergic function","volume":"46","author":"Samnick","year":"2003","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB21","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1161\/01.CIR.0000016047.19488.91","article-title":"Identification of a novel redox-sensitive gene, Id3, which mediates angiotensin II-induced cell growth","volume":"105","author":"Mueller","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB22","doi-asserted-by":"crossref","unstructured":"Werdan K, Erdmann E: Preparation und culture of embryonic and neonatal heart muscle cells: Modification of transport activity. In: Fleischer S, Fleischer B, editors. Biomembranes part I. Methods in enzymology, Vol. 173. San Diego, New York, London, Tokyo, Toronto: Academic Press, New York; 1989, p. 643-62","DOI":"10.1016\/S0076-6879(89)73042-1"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB23","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0022-2828(86)80939-7","article-title":"Cell cultures of adult cardiomyocytes as models of the myocardium","volume":"18","author":"Jacobson","year":"1986","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s00395-002-0360-0","article-title":"Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo","volume":"97","author":"Zhao","year":"2002","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB25","doi-asserted-by":"crossref","unstructured":"Hoffman BB, Hu ZW. Alpha(1)-adrenoceptors (alpha(1)-AR) and vascular smooth muscle cell growth. Prostate suppl 2000;9:29-33","DOI":"10.1002\/1097-0045(2000)45:9+<29::AID-PROS7>3.0.CO;2-Z"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0008-6363(00)00294-7","article-title":"Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes","volume":"49","author":"Sun","year":"2001","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB27","first-page":"897","article-title":"Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine","volume":"26","author":"Tobes","year":"1985","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB28","first-page":"3920","article-title":"Sodium dependency of uptake of norepinephrine and m-iodobenzylguanidine into cultured human pheochromocytoma cells","volume":"47","author":"Jaques","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB29","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s002590050043","article-title":"Influence of drugs on myocardial iodine-123 metaiodobenzylguanidine uptake in rabbit myocardium","volume":"27","author":"Mayer","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0969-8051(98)00015-8","article-title":"Transcapillary transport of metaiodobenzylguanidine (MIBG) in isolated rat heart","volume":"25","author":"DeGrado","year":"1998","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB31","first-page":"1085","article-title":"ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure","volume":"38","author":"Takeishi","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB32","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/hrt.76.3.218","article-title":"Increased myocardial [123I]-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure","volume":"76","author":"Somsen","year":"1996","journal-title":"Heart"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB33","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0735-1097(98)00261-7","article-title":"Comparison of effects of enalapril and nitrendipine on cardiac sympathetic nervous system in essential hypertension","volume":"32","author":"Sakata","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB34","first-page":"1620","article-title":"Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function","volume":"38","author":"Sisson","year":"1987","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB35","first-page":"358","article-title":"Imaging the primate adrenal medulla with [123I] and [131I]meta-iodobenzylguanidine","volume":"22","author":"Wieland","year":"1981","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2003.12.007_BIB36","first-page":"544","article-title":"Renal excretion of iodine-131 labeled meta-iodobenzylguanidine and metabolites after therapeutic doses in patients suffering from different neural crest-derived tumours","volume":"24","author":"Wafelman","year":"1997","journal-title":"Eur J Nucl Med"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805104000150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805104000150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T08:27:58Z","timestamp":1585729678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805104000150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0969805104000150"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2003.12.007","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}